For research use only. Not for therapeutic Use.
FHD-609（Cat No.:I041280）is a small molecule inhibitor that targets specific enzymes or proteins involved in cellular processes associated with diseases such as cancer and neurodegenerative disorders. It is under investigation for its potential therapeutic applications, particularly in oncology, where it aims to interfere with signaling pathways that drive tumor growth and survival. FHD-609 has shown promise in preclinical models for inhibiting cancer cell proliferation and promoting apoptosis. Research is ongoing to explore its efficacy and safety profile, with hopes of developing it into an effective treatment for various malignancies and related conditions.
| CAS Number | 2676211-64-4 |
| Synonyms | (3S)-3-[5-[7-[[1-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione |
| Molecular Formula | C47H56N8O6 |
| Purity | ≥95% |
| IUPAC Name | (3S)-3-[5-[7-[[1-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione |
| InChI | InChI=1S/C47H56N8O6/c1-50-26-37(35-22-42(53-13-4-14-53)48-23-36(35)45(50)58)32-19-40(60-2)38(41(20-32)61-3)27-51-15-9-30(10-16-51)24-52-17-11-47(12-18-52)28-54(29-47)33-6-5-31-25-55(46(59)34(31)21-33)39-7-8-43(56)49-44(39)57/h5-6,19-23,26,30,39H,4,7-18,24-25,27-29H2,1-3H3,(H,49,56,57)/t39-/m0/s1 |
| InChIKey | OBNRBCUHEAAFPS-KDXMTYKHSA-N |
| SMILES | CN1C=C(C2=CC(=NC=C2C1=O)N3CCC3)C4=CC(=C(C(=C4)OC)CN5CCC(CC5)CN6CCC7(CC6)CN(C7)C8=CC9=C(CN(C9=O)[C@H]1CCC(=O)NC1=O)C=C8)OC |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
